Cited by 164Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchHealth, Environment, Cognitive Aging

The DOI matches its Crossref record; 264 of the 268 references it cites were found in a registry or an index.

Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine

Open access

Eid, Aseel, Mhatre, Isha, Richardson, Jason R.·2019·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2019.03.005PMC PMC6827882

Open this paper in CoChat — free account

Abstract

Alzheimer's disease (AD) is the leading cause of dementia in the United States and afflicts >5.7 million Americans in 2018. Therapeutic options remain extremely limited to those that are symptom targeting, while no drugs have been approved for the modification or reversal of the disease itself. Risk factors for AD including aging, the female sex, as well as carrying an APOE4 genotype. These risk factors have been extensively examined in the literature, while less attention has been paid to modifiable risk factors, including lifestyle, and environmental risk factors such as exposures to air pollution and pesticides. This review highlights the most recent data on risk factors in AD and identifies gene by environment interactions that have been investigated. It also provides a suggested framework for a personalized therapeutic approach to AD, by combining genetic, environmental and lifestyle risk factors. Understanding modifiable risk factors and their interaction with non-modifiable factors (age, susceptibility alleles, and sex) is paramount for designing personalized therapeutic interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2019.03.005

Cites

264 of 264 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Air pollution and health
Brunekreef, B., & Holgate, S. T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11274-8 · Cited by 4,701
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Impact of pesticides use in agriculture: their benefits and hazards
Aktar, M. W., Sengupta, D., & Chowdhury, A. (2009) · Interdisciplinary Toxicology · doi:10.2478/v10102-009-0001-7 · Cited by 3,588
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459

Show all 268 references

Sorted by citations

Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“They may achieve this by altering biological pathways and genetic susceptibility, 23,84 – 86 making it challenging to pinpoint a direct cause of clinical pathology in AD.”
Background
Astrocytes in heavy metal neurotoxicity and neurodegeneration
Li, B.-M., Xia, M.-S., Zorec, R., Parpura, V., & Verkhratsky, A. (2021) · Brain Research · doi:10.1016/j.brainres.2020.147234 · Cited by 160
Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
Alsubaie, M. G., Luo, S., & Shaukat, K. (2024) · Machine Learning and Knowledge Extraction · doi:10.3390/make6010024 · Cited by 156
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
“across populations, including educational attainment, obesity, cholesterol levels, social isolation, alcohol consumption, and exposure to pesticides [269, 270].”
Background
Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment
Iaccarino, L., Joie, R. L., Lesman‐Segev, O. H., Lee, E. Y., Hanna, L., Allen, I. E., Hillner, B. E., Siegel, B. A., Whitmer, R. A., Carrillo, M. C., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.3962 · Cited by 125
Redox signaling at the crossroads of human health and disease
Zuo, J., Zhang, Z., Luo, M., Zhou, L., Nice, E. C., Zhang, W., Wang, C., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.127 · Cited by 123
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era
Gemmati, D., Varani, K., Bramanti, B., Piva, R., Bonaccorsi, G., Trentini, A., Manfrinato, M. C., Tisato, V., Carè, A., & Bellini, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010296 · Cited by 120
APOE Genotype and Alzheimer’s Disease: The Influence of Lifestyle and Environmental Factors
Angelopoulou, E., Paudel, Y. N., Papageorgiou, S. G., & Piperi, C. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00295 · Cited by 109
The association between toxic pesticide environmental exposure and Alzheimer’s disease: A scientometric and visualization analysis
Li, Y., Fang, R., Liu, Z., Jiang, L., Zhang, J., Li, H., Liu, C., & Li, F. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.128238 · Cited by 96
The Effects of Chronic Exposure to Ambient Traffic-Related Air Pollution on Alzheimer’s Disease Phenotypes in Wildtype and Genetically Predisposed Male and Female Rats
Patten, K. T., Valenzuela, A. E., Wallis, C., Berg, E. L., Silverman, J. L., Bein, K. J., Wexler, A. S., & Lein, P. J. (2021) · Environmental Health Perspectives · doi:10.1289/ehp8905 · Cited by 92
Multi-omics approaches for understanding gene-environment interactions in noncommunicable diseases: techniques, translation, and equity issues
Alemu, R. G., Sharew, N. T., Arsano, Y. Y., Ahmed, M. B., Ayele, F. T., Baye, T. M., & Amare, A. T. (2025) · Human Genomics · doi:10.1186/s40246-025-00718-9 · Cited by 99
Links between Cognitive Status and Trace Element Levels in Hair for an Environmentally Exposed Population: A Case Study in the Surroundings of the Estarreja Industrial Area
Cabral-Pinto, M. M. S., Reis, A. P. M., Almeida, A. A., Pinto, E., Neves, O., Inácio, M., Gerardo, B., Freitas, S., Simões, M. R., Dinis, P. A., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16224560 · Cited by 84
The Application of Artificial Intelligence in the Genetic Study of Alzheimer’s Disease
Mishra, R., & Li, B. (2020) · Aging and Disease · doi:10.14336/ad.2020.0312 · Cited by 85
Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease
Tang, B. L. (2020) · Toxics · doi:10.3390/toxics8020021 · Cited by 84
APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos‐investigation of neurocognitive aging (HCHS/SOL)
Granot‐Hershkovitz, E., Tarraf, W., Kurniansyah, N., Daviglus, M., Isasi, C. R., Kaplan, R., Lamar, M., Perreira, K. M., Wassertheil‐Smoller, S., Stickel, A., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12205 · Cited by 71
AlCl3 induced learning and memory deficit in zebrafish
Kaur, K., Narang, R. K., & Singh, S. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.07.004 · Cited by 71
Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder
Fišar, Z., Hansíková, H., Křížová, J., Jirák, R., Kitzlerová, E., Zvěřová, M., Hroudová, J., Wenchich, L., Zeman, J., & Raboch, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.013 · Cited by 64
Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Popescu, C., Munteanu, C., Anghelescu, A., Ciobanu, V., Spînu, A., Andone, I., Mandu, M., Bistriceanu, R., Băilă, M., Postoiu, R.-L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011272 · Cited by 61
Air pollution interacts with genetic risk to influence cortical networks implicated in depression
Li, Z., Yan, H., Zhang, X., Shah, S., Yang, G., Chen, Q., Han, S., Zhang, D., Weinberger, D. R., Yue, W., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109310118 · Cited by 51
Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study
Xicota, L., Ichou, F., Lejeune, F.-X., Colsch, B., Tenenhaus, A., Leroy, I., Fontaine, G., Lhomme, M., Bertin, H., Habert, M.-O., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.051 · Cited by 51
Environmental Risk Factors for Early-Onset Alzheimer’s Dementia and Frontotemporal Dementia: A Case-Control Study in Northern Italy
Adani, G., Filippini, T., Garuti, C., Malavolti, M., Vinceti, G., Zamboni, G., Tondelli, M., Galli, C., Costa, M., Vinceti, M., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17217941 · Cited by 55
Genetic susceptibility and lifestyle modify the association of long-term air pollution exposure on major depressive disorder: a prospective study in UK Biobank
Li, D., Xie, J., Wang, L., Sun, Y., Hu, Y., & Tian, Y. (2023) · BMC Medicine · doi:10.1186/s12916-023-02783-0 · Cited by 49
Supplementation with Nicotinamide Riboside Reduces Brain Inflammation and Improves Cognitive Function in Diabetic Mice
Lee, H. J., & Yang, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174196 · Cited by 50
Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients
Yaghmaei, E., Lu, H., Ehwerhemuepha, L., Zheng, J., Danioko, S., Rezaie, A., Sajjadi, S. A., & Rakovski, C. (2024) · Communications Medicine · doi:10.1038/s43856-024-00527-6 · Cited by 47
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease
Zhang, T., Kim, B. M., & Lee, T. H. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00395-5 · Cited by 49
Addressing the Discrepancies Between Animal Models and Human Alzheimer’s Disease Pathology: Implications for Translational Research
Polis, B., & Samson, A. O. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240058 · Cited by 43
Brain Disorders and Chemical Pollutants: A Gap Junction Link?
Mesnil, M., Defamie, N., Naus, C. C. G., & Sarrouilhe, D. (2020) · Biomolecules · doi:10.3390/biom11010051 · Cited by 45
Metabolic determinants of Alzheimer’s disease: A focus on thermoregulation
Tournissac, M., Leclerc, M., Valentin‐Escalera, J., Vandal, M., Bosoi, C. R., Planel, E., & Calon, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101462 · Cited by 41
Environmental Toxins and Alzheimer’s Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation
Dhapola, R., Sharma, P., Kumari, S., Bhatti, J. S., & HariKrishnaReddy, D. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03805-x · Cited by 41
Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs
Millan, M. J., Dekeyne, A., Gobert, A., Brocco, M., la Cour, C. M., Ortuno, J., Watson, D. J., & Fone, K. C. F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108099 · Cited by 38
Do glutathione and copper interact to modify Alzheimer's disease pathogenesis?
Ho, T., Ahmadi, S., & Kerman, K. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.025 · Cited by 37
Role of Astrocytes in Manganese Neurotoxicity Revisited
Ke, T., Sidoryk‐Wȩgrzynowicz, M., Pajarillo, E. A. B., Rizor, A., Soares, F. A. A., Lee, E.-S., & Aschner, M. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02881-7 · Cited by 35
Personalizing progressive changes to brain structure in Alzheimer's disease using normative modeling
Verdi, S., Rutherford, S. E., Fraza, C., Tosun, D., Altmann, A., Rakêt, L. L., Schott, J. M., Marquand, A. F., Cole, J. H., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14174 · Cited by 49
Education Exerts Different Effects on Cognition in Individuals with Subjective Cognitive Decline and Cognitive Impairment: A Population-Based Study
Chen, G., Zhao, M., Yang, K. Y., Lin, H., Han, C., Wang, X., & Han, Y. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201170 · Cited by 35
The role of the gut microbiome in mediating neurotoxic outcomes to PCB exposure
Rude, K. M., Keogh, C. E., & Gareau, M. G. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.010 · Cited by 31
Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer’s Disease
Štrac, D. Š., Konjevod, M., Perković, M. N., Tudor, L., Erjavec, G. N., & Pivac, N. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200317092310 · Cited by 31
Effects of DDT on Amyloid Precursor Protein Levels and Amyloid Beta Pathology: Mechanistic Links to Alzheimer’s Disease Risk
Eid, A., Mhatre‐Winters, I., Sammoura, F. M., Edler, M. K., von Stein, R., Hossain, M. M., Han, Y., Lisci, M., Carney, K., Konsolaki, M., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10576 · Cited by 31
Self-citation
Going beyond established model systems of Alzheimer’s disease: companion animals provide novel insights into the neurobiology of aging
de Sousa, A. A., Dames, B. A. R., Graff, E. C., Mohamedelhassan, R., Vassilopoulos, T., & Charvet, C. J. (2023) · Communications Biology · doi:10.1038/s42003-023-05034-3 · Cited by 36
Exploring the Causal Pathway From Telomere Length to Alzheimer’s Disease: An Update Mendelian Randomization Study
Gao, K., Chen, W., Zhu, J. L., Wang, X., Chen, G., Luo, Y., Zhang, D., Yue, W., & Yu, H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00843 · Cited by 29
Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 Mice
Hollinger, K. R., Zhu, X., Khoury, E. S., Thomas, A. G., Liaw, K., Tallon, C., Wu, Y., Prchalová, E., Kamiya, A., Rojas, C. J., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190588 · Cited by 28
Decoding the role of the CCL2/CCR2 axis in Alzheimer’s disease and innovating therapeutic approaches: Keeping All options open
Arfaei, R., Mikaeili, N., Daj, F., Boroumand, A., Kheyri, A., Yaraghi, P., Shirzad, Z., Keshavarz, M., Hassanshahi, G., Jafarzadeh, A., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112328 · Cited by 27
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 33
APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer’s Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset
Rabipour, S., Rajagopal, S., Yu, E., Pasvanis, S., Lafaille‐Magnan, M., Breitner, J. C. S., & Rajah, M. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191292 · Cited by 27
Disease‐specific interactome alterations via epichaperomics: the case for Alzheimer’s disease
Ginsberg, S. D., Neubert, T. A., Sharma, S., Digwal, C. S., Yan, P., Timbus, C., Wang, T., & Chiosis, G. (2021) · FEBS Journal · doi:10.1111/febs.16031 · Cited by 28
Exploring Alzheimer's disease treatment: Established therapies and novel strategies for future care
Soni, U., Singh, K., Jain, D., & Pujari, R. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177520 · Cited by 28
Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Microglia from APOE Targeted Replacement Mice
Mhatre‐Winters, I., Eid, A., Han, Y., Tieu, K., & Richardson, J. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179829 · Cited by 26
Self-citation
Insomnia and risk of dementia in a large population‐based study with 11‐year follow‐up: The HUNT study
Selbæk‐Tungevåg, S., Selbæk, G., Strand, B. H., Myrstad, C., Livingston, G., Lydersen, S., Bergh, S., & Ernstsen, L. (2023) · Journal of Sleep Research · doi:10.1111/jsr.13820 · Cited by 25
Genetic influences on brain and cognitive health and their interactions with cardiovascular conditions and depression
Zhukovsky, P., Tio, E. S., Coughlan, G., Bennett, D. A., Wang, Y., Hohman, T. J., Pizzagalli, D. A., Mulsant, B. H., Voineskos, A. N., & Felsky, D. (2024) · Nature Communications · doi:10.1038/s41467-024-49430-7 · Cited by 25
A gene–environment interplay between omega‐3 supplementation and APOE ε4 provides insights for Alzheimer’s disease precise prevention amongst high‐genetic‐risk population
Li, L., Xu, W., Tan, C., Cao, X., Wei, B., Dong, C., Tan, L., & Initiative, A. D. N. (2021) · European Journal of Neurology · doi:10.1111/ene.15160 · Cited by 23
The Impact of Environmental Factors on 5-Hydroxymethylcytosine in the Brain
Kochmanski, J. J., & Bernstein, A. I. (2020) · Current Environmental Health Reports · doi:10.1007/s40572-020-00268-3 · Cited by 20
Enhancing cognitive function in older adults: dietary approaches and implications
Polis, B., & Samson, A. O. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1286725 · Cited by 21
Genetic and non-genetic factors associated with the phenotype of exceptional longevity & normal cognition
Han, B., Chen, H., Yao, Y., Liu, X., Nie, C., Min, J., Zeng, Y., & Lutz, M. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-75446-2 · Cited by 21
Neurodegenerative effects of air pollutant Particles: Biological mechanisms implicated for Early-Onset Alzheimer’s disease
Gunawan, C., Fleming, C. L., Irga, P. J., Wong, R. J., Amal, R., Torpy, F. R., Golzan, M., & McGrath, K. C. Y. (2024) · Environment International · doi:10.1016/j.envint.2024.108512 · Cited by 23
Impact of Apolipoprotein E ε4 in Alzheimer’s Disease: A Meta-Analysis of Voxel-Based Morphometry Studies
Bailey, M., Ilchovska, Z. G., Hosseini, A. A., & Jung, J. (2024) · Journal of Clinical Neurology · doi:10.3988/jcn.2024.0176 · Cited by 26
NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer’s Disease
Shi, J., Wang, B., Jiang, T., Gao, L., Zhang, Y., & Xu, J. L. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200359 · Cited by 20
Global perspectives on myopia and pathologic myopia: From environmental drivers to precision medicine
Pan, C., Dong, X., Lança, C., Wang, Y., Saw, S., He, X., Hu, D., Fan, Q., Grzybowski, A. E., & Ohno‐Matsui, K. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101415 · Cited by 21
Prediction of Alzheimer’s Disease by a Novel Image-Based Representation of Gene Expression
Kalkan, H., Akkaya, U. M., Gültekin, G. İ., & Sánchez‐Pérez, A. M. (2022) · Genes · doi:10.3390/genes13081406 · Cited by 20
Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review
Mohammadi, S., Ghaderi, S., & Fatehi, F. (2024) · Aging Medicine · doi:10.1002/agm2.12363 · Cited by 18
Gene surgery
El-Kenawy, A. E.-M., Benarba, B., Neves, A. F., Araújo, T. G., Tan, B. L., & Gouri, A. (2019) · EXCLI journal · doi:10.17179/excli2019-1833 · Cited by 16
The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study
Foote, I. F., Jacobs, B. M., Mathlin, G., Watson, C. J., Bothongo, P. L., Waters, S., Dobson, R., Noyce, A. J., Bhui, K. S., Korszun, A., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.02.016 · Cited by 16
Interaction between aluminum exposure and ApoEε4 gene on cognitive function of in-service workers.
Wang, S., Xue, Y., Zhang, J., Meng, H., Zhang, J., Li, X., Zhang, Z., Li, H., Pan, B., Lu, X., et al. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.138282 · Cited by 17
Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models
Gurdon, B., & Kaczorowski, C. C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105558 · Cited by 16
Hippocampal but Not Serum Cytokine Levels Are Altered by Traffic-Related Air Pollution in TgF344-AD and Wildtype Fischer 344 Rats in a Sex- and Age-Dependent Manner
Patten, K. T., Valenzuela, A. E., Wallis, C., Harvey, D. J., Bein, K. J., Wexler, A. S., Gorin, F. A., & Lein, P. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.861733 · Cited by 17
Genetic and environmental risk factors for dementia in African adults: A systematic review
Donkor, D. M., Marfo, E., Bockarie, A. S., Tettevi, E. J., Antwi, M. H., Dogah, J., Osei, G. N., & Simpong, D. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70220 · Cited by 15
Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer’s disease
Onisiforou, A., Christodoulou, C. C., Zamba‐Papanicolaou, E., Zanos, P., & Georgiou, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1345498 · Cited by 15
ChemNTP: Advanced Prediction of Neurotoxicity Targets for Environmental Chemicals Using a Siamese Neural Network
Zhang, L., Yao, T., Luo, J., Yi, H., Han, X., Pan, W., Xue, Q., Liu, X., Fu, J., & Zhang, A. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c10081 · Cited by 15
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials
Bellver‐Sanchís, A., Ribalta‐Vilella, M., Irisarri, A., Gehlot, P., Choudhary, B. S., Jana, A., Vyas, V. K., Banerjee, D. R., Pallàs, M., Guerrero, A., et al. (2025) · Medicinal Research Reviews · doi:10.1002/med.22096 · Cited by 14
Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment
Clark, A. L., Initiative, A. D. N., Weigand, A. J., Thomas, K. R., Solders, S. K., Delano‐Wood, L., Bondi, M. W., Bernier, R. A., Sundermann, E. E., Banks, S. J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201382 · Cited by 14
The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders
Sarkar, S. K., Gubert, C., & Hannan, A. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106276 · Cited by 15
Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway
Ramírez-Expósito, M. J., Martínez-Martos, J. M., Cantón-Habas, V., & Carrera-González, M. P. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201111103024 · Cited by 17
Using machine intelligence to uncover Alzheimer’s disease progression heterogeneity
Qorri, B., Tsay, M., Agrawal, A., Au, R., & Gracie, J. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00026 · Cited by 13
Genomic Insights into Dementia: Precision Medicine and the Impact of Gene-Environment Interaction
Tripathi, A., Pandey, V. K., Sharma, G., Sharma, A. R., Taufeeq, A., Jha, A. K., & Kim, J. (2024) · Aging and Disease · doi:10.14336/ad.2024.0322 · Cited by 13
Effect of Chronic Cadmium Exposure on Brain and Liver Transporters and Drug-Metabolizing Enzymes in Male and Female Mice Genetically Predisposed to Alzheimer’s Disease
Wang, H., Zhang, L., Xia, Z., & Cui, J. Y. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000453 · Cited by 13
Excessive Alcohol Use as a Risk Factor for Alzheimer’s Disease: Epidemiological and Preclinical Evidence
Anton, P. E., Maphis, N. M., Linsenbardt, D. N., & Coleman, L. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-81908-7_10 · Cited by 12
The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship
Li, Q. S., Tian, C., Hinds, D. A., & Seabrook, G. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241552 · Cited by 12
Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128
Bellver‐Sanchís, A., Ávila-López, P. A., Tic, I., Valle‐García, D., Ribalta‐Vilella, M., Labrador, L., Banerjee, D. R., Guerrero, A., Casadesús, G., Poulard, C., et al. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.393102 · Cited by 11
Potential mechanisms of non-coding RNA regulation in Alzheimer’s disease
Sun, Y., Pang, X., Huang, X., Liu, D., Huang, J., Zheng, P., Wei, Y., & Pang, C.-Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00696 · Cited by 12
Adherence to life’s essential 8 is associated with delayed white matter aging
Feng, L., Ye, Z., Pan, Y., McCoy, R. G., Mitchell, B. D., Kochunov, P. V., Thompson, P. M., Chen, J., Liang, M., Nguyen, T. T., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105723 · Cited by 12
High-Fat Diet-Induced Excessive Accumulation of Cerebral Cholesterol Esters and Microglial Dysfunction Exacerbate Alzheimer's Disease Pathology in APPNL−G−F mice
Yang, S., Miyazaki, H., Wannakul, T., Amo, E., Saido, T. C., Saito, T., Sasaguri, H., Maekawa, M., & Owada, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05052-8 · Cited by 11
Amyloid-beta (Aβ1–42)-induced paralysis in Caenorhabditis elegans is reduced through NHR-49/PPARalpha
Leiteritz, A., Baumanns, S., & Wenzel, U. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135042 · Cited by 11
Ozone and Particulate Matter Exposure and Alzheimer’s Disease: A Review of Human and Animal Studies
Liu, R.-M., Chong, Z., & Chen, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200435 · Cited by 11
Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline
Barnett, A. M., McNair, E. M., Dawkins, L., Zou, J., Nikolova, V. D., Moy, S. S., Sutherland, G. T., Stevens, J., Colie, M., Katemboh, K., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70486 · Cited by 12
Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns
Thakur, A., Rana, M., Vanjani, S., Liou, K.-C., Taliyan, R., Nepali, K., & Yang, C. (2026) · Medicinal Research Reviews · doi:10.1002/med.70047 · Cited by 10
Inducible and Conditional Activation of Adult Neurogenesis Rescues Cadmium-Induced Hippocampus-Dependent Memory Deficits in ApoE4-KI Mice
Matsushita, M. T., Wang, H., Abel, G. M., & Xia, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119118 · Cited by 9
Chronic Social and Psychological Stress Impact Select Neuropathologies in the PS19 Mouse Model of Tauopathy
Lyons, C. E., Graves, S. I., Razzoli, M., Jeganathan, K. B., Mansk, R. P., McGonigle, S., Sabarinathan, N., van Deursen, J. M., Baker, D. J., & Bartolomucci, A. (2023) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001256 · Cited by 9
Personalising Alzheimer’s Disease progression using brain atrophy markersPreprint
Verdi, S., Rutherford, S. E., Fraza, C., Tosun, D., Altmann, A., Rakêt, L. L., Schott, J. M., Marquand, A. F., & Cole, J. H. (2023) · medRxiv · doi:10.1101/2023.06.15.23291418 · Cited by 9
Disentangling sex-dependent effects of APOE on diverse trajectories of cognitive decline in Alzheimer's disease
Ma, H., Shi, Z., Kim, M., Liu, B., Smith, P. J., Liu, Y., & Guorong Wu, A. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120609 · Cited by 12
Loss of the mitochondrial protein mitoNEET in mice is associated with cognitive impairments and increased neuroinflammation
Geldenhuys, W. J., Wilson, G. N., Hernandez, K., Monaghan, K., Smith, K., Cicala, D. S., Poling, T. J., Walton, J. C., Han, P., & Huber, J. D. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241302456 · Cited by 9
Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer’s disease
Kanda, A., Rani, A., & Mazumder, A. (2025) · Pharmacogenomics · doi:10.1080/14622416.2025.2560296 · Cited by 8
GBDTL2E: Predicting lncRNA-EF Associations Using Diffusion and HeteSim Features Based on a Heterogeneous Network
Wang, J., Kuang, Z., Ma, Z., & Han, G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00272 · Cited by 8
Exploring the potential impact of multi-factor precision interventions in Alzheimer’s disease with system dynamics
Uleman, J. F., Melis, R. J. F., Hoekstra, A. G., Rikkert, M. G. M. O., & Quax, R. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104462 · Cited by 8
Epistatic Features and Machine Learning Improve Alzheimer’s Disease Risk Prediction Over Polygenic Risk Scores
Hermes, S., Cady, J., Armentrout, S. L., O’Connor, J., Holdaway, S. C., Cruchaga, C., Wingo, T. S., Greytak, E. M., & Initiative, T. A. D. N. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230236 · Cited by 10
A mini review of polysaccharides from Zanthoxylum bungeanum maxim: Their extraction, purification, structural characteristics, bioactivity and potential applications
Zhang, T., Zheng, J., Chen, M., Li, D., Sun, Y., Liu, R., & Sun, T. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137007 · Cited by 7
Alzheimer’s Disease and Oral Health from Clinical Challenges to Interdisciplinary Care: A Narrative Review
Tatarciuc, D., Curca, F. R., Virvescu, D. I., Butnaru, O., Goriuc, A., Bida, S. M., Luchian, I. A., Surlari, Z., Scurtu, M., Ursu, R. G., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196696 · Cited by 8
The Relationship Between Sleep Disturbance and Apolipoprotein E ε4 in Adults With Mild Cognitive Impairment and Alzheimer’s Disease Dementia: An Integrative Review
Wei, W., Wang, K., Shi, J., & Li, Z. (2022) · Biological Research For Nursing · doi:10.1177/10998004221081044 · Cited by 7
Multimodal analysis of disease onset in Alzheimer’s disease using Connectome, Molecular, and genetics data
Oh, S., Kim, S., Lee, J., Park, B., Won, J. H., & Park, H. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103660 · Cited by 7
Amaryllidaceae alkaloids from Lycoris suppress amyloid β-induced neurodegeneration in transgenic Caenorhabditis elegans CL2355
Hong, L., Ji, Y., Kennelly, E. J., Long, C., & Di, R. (2022) · Industrial Crops and Products · doi:10.1016/j.indcrop.2022.115798 · Cited by 7
Recent advancement in polysaccharides from Cornus officinalis Sieb. et Zucc.: Extractions, purifications, structural characteristics, bioactivities, and applications: A review
Cao, Y., Zhang, L., Liu, Y., Li, W., Wang, M., Liu, B., Li, X., Li, X., & Sun, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148852 · Cited by 6
Leading determinants of incident dementia among individuals with and without the apolipoprotein E ε4 genotype: a retrospective cohort study
Ye, S., Roccati, E., Wang, W., Zhu, Z., Kiburg, K., Huang, Y., Zhang, X., Zhang, X., Liu, J., Tang, S., et al. (2024) · BMC Neurology · doi:10.1186/s12883-024-03557-8 · Cited by 6
Poor Oral Health as a Risk Factor for Dementia in a Swedish Population: A Cohort Study with 40 Years of Follow-Up
He, F., Luo, H., Yin, L., Roosaar, A., Axéll, T., Zhao, H., & Ye, W. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-215177 · Cited by 6

Authors: Eid, A., Mhatre, I., & Richardson, J. R.
Affiliations: Florida International University (US)
Corresponding author: Richardson, Jason R.
ORCID: Richardson, Jason R.
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2019-07
Volume: 199
Pages: 173-187
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2019.03.005
PMC: PMC6827882
OpenAlex: W2922392851
Cited by: 164
References: 268
Citations by year: 2026: 21 · 2025: 28 · 2024: 34 · 2023: 20 · 2022: 15 · 2021: 13 · 2020: 24 · 2019: 9
FWCI: 1.80
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: NIH (R01ES021800, R01ES026057, R01ES026067-S2, U01NS108956)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
Keywords: Alzheimer's disease, gene-environment interaction, modifiable risk factors, lifestyle risk factors, air pollution exposure, pesticide exposure, APOE ε4, sex differences, aging, personalized medicine, precision medicine, dementia
MeSH terms: Alzheimer Disease, Animals, Humans, Risk Factors, Precision Medicine, Gene-Environment Interaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks